Latest news & insights
Ada Lovelace Day 2023: turning curiosity into a career
In this interview, Dr Karen Mullen discusses what inspired her to pursue a career in STEM, her tips for overcoming adversity, and how to encourage more women to consider careers in the industry.
Boyds’ Patrick Ginty presenting at the TOPRA Symposium
Senior Director of Regulatory Affairs Patrick Ginty will be speaking at the TOPRA Symposium, taking place in Lisbon from the 23-25 October. Patrick will be
Professor Alan Boyd welcomes the Innovative Devices Access Pathway (IDAP) pilot
Professor Alan Boyd welcomes the Innovative Devices Access Pathway (IDAP) pilot for medical devices that recently launched in the UK.
Boyds Regulatory experts join AAPS as guest speakers on Webinar
Boyds’ Regulatory experts, Dr Patrick Ginty and Dr Sabine Rühle, join AAPS as guest speakers for a Webinar “Highlighting US and European Regulatory Requirements for Gene and Cell Therapy Products”
Dr Harriet Gray Stephens reviews key complexities and emerging trends in early-phase oncology clinical trials for ATMPs
An article authored by Dr Harriet Gray Stephens MFPM, Pharmaceutical Physician in the Clinical and Medical Affairs team at Boyds, has been published in Cell & Gene Therapy Insights.
UK rejoins EU Horizon scheme: Professor Alan Boyd comments
The government has announced that the UK is to re-join the EU’s flagship scientific research scheme, Horizon. UK-based scientists and institutions will be able to apply for money from the £81bn (€95bn) fund from today. Associate membership had been agreed as part of the Brexit trade deal when the UK formally left the EU in 2020.
Webinar: How to successfully operationalize real-world data collection alongside expanded access programs
On 05 October, Boyds will be co-hosting a live webinar with Cisiv, discussing how to successfully operationalize real-world data collection alongside expanded access programs.
Boyds strengthens team with regulatory operations and publishing expertise
Boyds is pleased to announce the appointment of regulatory operations and publishing professional Michelle Hackney to lead our new in-house Regulatory Operations offering.
